UK Hospitals Face Rising Threat from Deadly Fungal Infection, Experts Warn
Candida auris poses a critical risk to vulnerable patients as cases climb across the country
A highly infectious and potentially deadly fungus, Candida auris, is spreading quietly through UK hospitals, according to a leaked memo from the UK Health Security Agency (UKHSA). The confidential report highlights “significant outbreaks” across the National Health Service, raising concerns about preparedness and patient safety.
Candida auris is particularly dangerous because it can remain dormant for years, surviving on surfaces and skin undetected. If it enters the bloodstream through cuts or abrasions, it can cause life-threatening infections, especially in people with weakened immune systems. Alarmingly, the fungus is showing resistance to multiple antifungal medications, making treatment increasingly challenging.
The memo reveals that the fungus has now been detected in 72 hospitals across the UK over the past two years, with nearly 500 cases recorded, including a significant outbreak at Guy’s and St Thomas’ Hospital in London, where 222 cases have been identified. In the past three months alone, ten additional hospitals have reported new infections.
The World Health Organization (WHO) classifies Candida auris as a “critical priority fungal pathogen”, with global mortality rates approaching 60% within 90 days of infection. While the UK’s mortality rate is expected to be lower, health experts are urging transparency and immediate action to protect patients.
Rohini Manuel of UKHSA commented:
“UKHSA is working closely with NHS trusts to investigate outbreaks and limit the spread of Candida auris. While invasive infections remain rare, we are supporting hospitals to strengthen detection and infection control measures.”
Experts warn that the fungus is extremely difficult to eradicate from hospital environments, with traces found on radiators, windowsills, and medical equipment. In April, UKHSA classified Candida auris as a Schedule 2 pathogen, putting it on par with some of the UK’s most serious infectious diseases.
Health officials are urging NHS staff, hospitals, and the public to remain vigilant and follow strict hygiene protocols. Tory health spokesman Stuart Andrew said:
“Protecting national health demands honesty and openness about the scale of the risk. Public confidence and safety depend on transparency.”
With cases rising and no vaccine currently available, Candida auris represents a critical challenge for UK hospitals — highlighting the urgent need for enhanced infection control, rapid reporting, and robust monitoring to safeguard patients nationwide.
